The results showed that the expression level of VASP in breast cancer tissues was significantly higher than that in normal breast tissues, and the expression level of VASP in HER2-Enriched and Basal-like breast cancer was higher than that in luminal A/B breast cancer (Figure 1A). This evidence concerns the gene VASP and breast carcinoma.